| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.73B | 39.84B | 37.29B | 35.66B | 35.51B | 35.83B |
| Gross Profit | 17.77B | 17.94B | 17.66B | 16.23B | 15.75B | 15.73B |
| EBITDA | 2.42B | 1.83B | 2.56B | 2.57B | 2.22B | 2.24B |
| Net Income | 1.16B | 1.38B | 1.25B | 1.34B | 985.73M | 972.68M |
Balance Sheet | ||||||
| Total Assets | 28.60B | 27.86B | 28.13B | 27.78B | 27.69B | 28.54B |
| Cash, Cash Equivalents and Short-Term Investments | 1.54B | 1.46B | 1.37B | 1.41B | 1.90B | 2.13B |
| Total Debt | 5.45B | 3.19B | 4.44B | 5.24B | 6.51B | 7.70B |
| Total Liabilities | 12.92B | 10.80B | 12.42B | 13.11B | 14.21B | 15.84B |
| Stockholders Equity | 15.51B | 16.75B | 15.54B | 14.52B | 13.34B | 12.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.41B | 993.80M | 938.12M | 1.35B | 2.23B |
| Operating Cash Flow | 0.00 | 2.38B | 1.49B | 1.59B | 1.77B | 2.75B |
| Investing Cash Flow | 0.00 | -834.73M | -492.20M | -583.06M | -561.28M | -443.56M |
| Financing Cash Flow | 0.00 | -1.46B | -1.04B | -1.49B | -1.44B | -1.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥7.15B | 4.74 | ― | 3.35% | 6.84% | 9.89% | |
77 Outperform | ¥59.44B | 5.85 | 16.91% | 2.28% | 8.57% | 43.80% | |
74 Outperform | ¥362.82B | 6.04 | 11.34% | 3.38% | 4.23% | -14.22% | |
73 Outperform | ¥102.25B | 5.86 | ― | 3.74% | -3.93% | 3.02% | |
69 Neutral | ¥365.60B | 11.28 | ― | 3.13% | 1.59% | 18.87% | |
67 Neutral | ¥478.77B | 5.52 | ― | 3.37% | 2.89% | 17.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |